HealthStream (NASDAQ:HSTM) Stock: Insider Tate Deborah Taylor Sells 3,281 Shares

HealthStream, Inc. (NASDAQ:HSTM) Director Deborah Tate sold 3,281 shares of HealthStream stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $32.19, for a total transaction of $105,615.39. Following the sale, the director directly owned 21,418 shares in the company, valued at approximately $689,445.42. This trade represents a 13.28% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

HealthStream Stock Down 2.4%

Shares of NASDAQ HSTM opened at $28.89 on Friday. The firm has a 50-day simple moving average of $31.20 and a 200-day simple moving average of $25.83. The stock has a market capitalization of $844.17 million, a price-to-earnings ratio of 41.27, a price-to-earnings-growth ratio of 3.01 and a beta of 0.45. HealthStream, Inc. has a 52 week low of $19.50 and a 52 week high of $35.60.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings results on Monday, November 2nd. The technology company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.02. HealthStream had a net margin of 6.25% and a return on equity of 6.37%. The firm had revenue of $83.31 million for the quarter, compared to analyst estimates of $82.24 million. As a group, equities research analysts expect that HealthStream, Inc. will post 0.80 EPS for the current year.

HealthStream Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Monday, November 16th will be given a dividend of $0.0350 per share. The ex-dividend date is Monday, November 16th. This represents a $0.14 dividend on an annualized basis and a yield of 0.5%. HealthStream’s dividend payout ratio (DPR) is presently 20.00%.

More HealthStream News

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: Buy rating upgrade: Zacks upgraded HSTM to Rank #2 (Buy), citing improving earnings prospects, which could support investor optimism. Zacks article
• Positive Sentiment: Raised guidance: HealthStream lifted its outlook, a potentially positive sign for expected business performance, although the article raises the question of whether prior gains already reflect the news. Yahoo Finance article
• Neutral Sentiment: Analyst views remain cautious: Canaccord Genuity raised its price target to $32 from $29 but maintained a Hold rating; Craig Hallum also moved its rating to Hold. These calls suggest limited conviction despite the higher target. Canaccord rating information Craig Hallum rating article
• Negative Sentiment: Multiple insider sales: On November 5, EVP Michael Manning Collier, CFO Scott Alexander Roberts, Director Deborah Tate and EVP Kevin O’Hara sold a combined 38,081 shares. Each reduced their individual holdings, a cluster of transactions that may weigh on sentiment, though insider sales alone do not establish a change in the company’s outlook. Collier SEC filing Roberts SEC filing Tate SEC filing O’Hara SEC filing

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Canaccord Genuity Group raised their target price on HealthStream from $29.00 to $32.00 and gave the stock a “hold” rating in a research note on Wednesday. Craig Hallum cut shares of HealthStream from a “buy” rating to a “hold” rating and set a $40.00 price target on the stock. in a research report on Tuesday, November 3rd. Wall Street Zen cut shares of HealthStream from a “buy” rating to a “hold” rating in a research report on Sunday. Weiss Ratings raised shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Finally, Citigroup restated a “market perform” rating on shares of HealthStream in a research report on Tuesday, October 27th. One equities research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $36.00.

Institutional Investors Weigh In On HealthStream

A number of hedge funds have recently bought and sold shares of the stock. Aberdeen Group plc acquired a new stake in HealthStream during the third quarter worth approximately $2,987,000. Russell Investments Group Ltd. grew its holdings in HealthStream by 12.0% during the third quarter. Russell Investments Group Ltd. now owns 92,038 shares of the technology company’s stock worth $2,736,000 after acquiring an additional 9,882 shares during the period. Illinois Municipal Retirement Fund increased its holdings in HealthStream by 3.7% in the third quarter. Illinois Municipal Retirement Fund now owns 11,755 shares of the technology company’s stock valued at $349,000 after buying an additional 423 shares in the last quarter. Bridge City Capital LLC increased its position in shares of HealthStream by 17.6% in the third quarter. Bridge City Capital LLC now owns 60,860 shares of the technology company’s stock valued at $1,808,000 after buying an additional 9,095 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of HealthStream in the third quarter valued at about $160,000. Institutional investors and hedge funds own 69.58% of the company’s stock.

HealthStream Company Profile

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.